Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Milestone ScientificMLSS +2.28%49 3-Year FCF Growth Rate is 25.20% as of Jun. 2026, which is 75% above its 10-year median of 14.40. GuruFocus rates MLSS with a GF Score™ of 49/100 and a GF Value™ of $0.60 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 587 Medical Devices & Instruments companies, Milestone Scientific ranks better than 58.43% on this metric.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 25.20% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 18.60% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 9.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Milestone Scientific was 55.20% per year. The lowest was -204.40% per year. And the median was 14.40% per year.
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
Milestone Scientific 3-Year FCF Growth Rate Related Terms
MLSS vs POCI, NEPH, HBIO: 3-Year FCF Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Milestone Scientific's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Milestone Scientific 3-Year FCF Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where Milestone Scientific's 3-Year FCF Growth Rate falls into.
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
What does a 3-Year FCF Growth Rate of 25.20% mean?
Milestone Scientific (MLSS) has a 3-Year FCF Growth Rate of 25.20% as of Jun. 2026. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Milestone Scientific and its competitors. This is 75% above median its historical median of 14.40. According to the industry distribution chart, Milestone Scientific ranks #244 out of 587 companies in the Medical Devices & Instruments industry, placing it in the top 41.6%.
Is Milestone Scientific's 3-Year FCF Growth Rate too high?
Milestone Scientific's current 3-Year FCF Growth Rate of 25.20% is 75% above median its 10-year median of 14.40. The Medical Devices & Instruments industry median 3-Year FCF Growth Rate is 18.00. Milestone Scientific's value of 25.20% is 40% above this industry median. Based on the distribution chart, Milestone Scientific ranks #244 out of 587 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Milestone Scientific has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Milestone Scientific's 3-Year FCF Growth Rate compare to POCI and NEPH?
According to the Medical Devices & Instruments industry distribution chart, Milestone Scientific ranks #244 out of 587 companies for 3-Year FCF Growth Rate. This puts Milestone Scientific in the upper half of its industry. The industry median 3-Year FCF Growth Rate is 18.00. Milestone Scientific's value of 25.20% is 40% above this benchmark. While the company's 10-year median is 14.40 vs. the industry median of 18.00, Milestone Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Medical Devices & Instruments company?
The median 3-Year FCF Growth Rate among Medical Devices & Instruments companies is 18.00, based on 587 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Milestone Scientific's current 3-Year FCF Growth Rate of 25.20% is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Milestone Scientific and its competitors. For the Medical Devices & Instruments industry, the median 3-Year FCF Growth Rate is 18.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Milestone Scientific's current 3-Year FCF Growth Rate is 25.20%, which is 75% above median its own 10-year median of 14.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milestone Scientific stock overvalued right now?
Based on GuruFocus' analysis, Milestone Scientific (MLSS) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.60, compared to a current price of $0.44 — trading 26% below its estimated fair value. The current 3-Year FCF Growth Rate is 25.20%, which is 75% above median its 10-year median of 14.40 and 40% above the Medical Devices & Instruments industry median of 18.00. Milestone Scientific's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For Milestone Scientific (MLSS), the current 3-Year FCF Growth Rate is 25.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Milestone Scientific (MLSS) Overvalued in 2026?
Based on GuruFocus' analysis, Milestone Scientific stock appears to be undervalued.
The current stock price of $0.44 is trading 26% below its estimated GF Value™ of $0.60.
GuruFocus considers Milestone Scientific to be Modestly Undervalued.
Key valuation signals for MLSS:
3-Year FCF Growth Rate: 25.20% (75% above median its 10-year median of 14.40)
GF Value™: $0.60 vs. price of $0.44 (26% below fair value)
Industry Position: 40% above the Medical Devices & Instruments median (#244 of 587)
No single metric tells the full story. See the MLSS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
49GF Score
Get the complete analysis for MLSS
3-Year FCF Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLSS has been successfully added to your 
